Hussman Strategic Advisors Inc. Makes New $1.11 Million Investment in The Pennant Group, Inc. (NASDAQ:PNTG)

Hussman Strategic Advisors Inc. purchased a new position in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 42,000 shares of the company's stock, valued at approximately $1,114,000. Hussman Strategic Advisors Inc. owned about 0.12% of The Pennant Group as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. FMR LLC boosted its stake in shares of The Pennant Group by 51.3% during the 3rd quarter. FMR LLC now owns 2,528,512 shares of the company's stock worth $90,268,000 after acquiring an additional 856,838 shares in the last quarter. Crewe Advisors LLC lifted its holdings in shares of The Pennant Group by 1.6% during the third quarter. Crewe Advisors LLC now owns 742,958 shares of the company's stock valued at $26,524,000 after purchasing an additional 11,927 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of The Pennant Group by 0.4% during the third quarter. Geode Capital Management LLC now owns 682,132 shares of the company's stock valued at $24,357,000 after purchasing an additional 2,963 shares during the last quarter. De Lisle Partners LLP boosted its position in shares of The Pennant Group by 7.6% in the 3rd quarter. De Lisle Partners LLP now owns 343,340 shares of the company's stock valued at $12,254,000 after purchasing an additional 24,321 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in The Pennant Group by 1.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 242,743 shares of the company's stock worth $8,666,000 after purchasing an additional 2,982 shares in the last quarter. Institutional investors own 85.88% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have commented on PNTG shares. Wells Fargo & Company assumed coverage on shares of The Pennant Group in a research note on Thursday, December 19th. They set an "equal weight" rating and a $33.00 price objective for the company. Oppenheimer upped their price target on shares of The Pennant Group from $34.00 to $37.00 and gave the company an "outperform" rating in a research report on Friday, November 8th. Finally, Truist Financial lowered their price objective on shares of The Pennant Group from $38.00 to $32.00 and set a "hold" rating on the stock in a research report on Monday, January 6th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat.com, The Pennant Group currently has a consensus rating of "Moderate Buy" and an average price target of $36.00.

The Pennant Group Price Performance

PNTG stock traded up $0.24 during midday trading on Tuesday, reaching $25.39. 103,021 shares of the company's stock traded hands, compared to its average volume of 184,321. The company has a 50-day simple moving average of $26.84 and a two-hundred day simple moving average of $30.69. The company has a market cap of $871.92 million, a price-to-earnings ratio of 37.33, a PEG ratio of 2.24 and a beta of 1.92. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.58. The Pennant Group, Inc. has a 1-year low of $16.28 and a 1-year high of $37.13.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.